載入...
Altered nuclear export signal recognition as a driver of oncogenesis
Altered expression of XPO1, the main nuclear export receptor in eukaryotic cells, has been observed in cancer and XPO1 has been a focus of anti-cancer drug development. However, mechanistic evidence for cancer-specific alterations in XPO1 function is lacking. Here, genomic analysis of 42,793 cancers...
Na minha lista:
| 發表在: | Cancer Discov |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6774834/ https://ncbi.nlm.nih.gov/pubmed/31285298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-19-0298 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|